These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23853750)

  • 1. Impact of closed-system drug transfer device on exposure of environment and healthcare provider to cyclophosphamide in Japanese hospital.
    Miyake T; Iwamoto T; Tanimura M; Okuda M
    Springerplus; 2013 Dec; 2(1):273. PubMed ID: 23853750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.
    Gurusamy KS; Best LM; Tanguay C; Lennan E; Korva M; Bussières JF
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012860. PubMed ID: 29582940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents.
    Wick C; Slawson MH; Jorgenson JA; Tyler LS
    Am J Health Syst Pharm; 2003 Nov; 60(22):2314-20. PubMed ID: 14652980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2021; 25(6):515-522. PubMed ID: 34807847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2022; 26(1):72-79. PubMed ID: 35081047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.
    Sessink PJ; Trahan J; Coyne JW
    Hosp Pharm; 2013 Mar; 48(3):204-12. PubMed ID: 24421463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringe plunger contamination by hazardous drugs: a comparative study.
    Smith ST; Szlaczky MC
    J Oncol Pharm Pract; 2014 Oct; 20(5):381-5. PubMed ID: 24598373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study.
    Simon N; Vasseur M; Pinturaud M; Soichot M; Richeval C; Humbert L; Lebecque M; Sidikou O; Barthelemy C; Bonnabry P; Allorge D; Décaudin B; Odou P
    PLoS One; 2016; 11(7):e0159052. PubMed ID: 27391697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.
    Sessink PJ; Connor TH; Jorgenson JA; Tyler TG
    J Oncol Pharm Pract; 2011 Mar; 17(1):39-48. PubMed ID: 20156932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PhaSeal® system: impact of its use on workplace contamination and duration of chemotherapy preparation.
    Favier B; Labrosse H; Gilles-Afchain L; Cropet C; Perol D; Chaumard N; Latour JF; Hild P
    J Oncol Pharm Pract; 2012 Mar; 18(1):37-45. PubMed ID: 21422148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe Cytotoxic Drug Preparation Using Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal).
    Garrigue P; Montana M; Ventre C; Savry A; Gauthier-Villano L; Pisano P; Pourroy B
    Int J Pharm Compd; 2016; 20(2):148-54. PubMed ID: 27323425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and reduction of hazardous drug surface contamination through the use of a novel closed-system transfer device coupled with a point-of-care hazardous drug detection system.
    Brechtelsbauer E
    Am J Health Syst Pharm; 2023 Mar; 80(7):435-444. PubMed ID: 36370411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.
    Harrison BR; Peters BG; Bing MR
    Am J Health Syst Pharm; 2006 Sep; 63(18):1736-44. PubMed ID: 16960258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of environmental contamination with hazardous drugs by surface wipe sampling.
    Sessink PJ; Tans B; Spriet I; Devolder D
    J Oncol Pharm Pract; 2024 Oct; 30(7):1181-1185. PubMed ID: 38115732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs.
    Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L
    Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.
    Clark BA; Sessink PJ
    J Oncol Pharm Pract; 2013 Jun; 19(2):99-104. PubMed ID: 23292973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Decontamination Efficacy of Cleaning Solutions on a Biological Safety Cabinet Workbench Contaminated by Cyclophosphamide.
    Adé A; Chauchat L; Frève JO; Gagné S; Caron N; Bussières JF
    Can J Hosp Pharm; 2017; 70(6):407-414. PubMed ID: 29298999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational exposure to chemotherapy of pharmacy personnel at a single centre.
    Ramphal R; Bains T; Goulet G; Vaillancourt R
    Can J Hosp Pharm; 2015; 68(2):104-12. PubMed ID: 25964681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.